Table 2.
Variants/mutations in Crohn's disease candidate genes and the alteration of intestinal microbiome
Ref. | Gene | Human/animal | Major findings |
[6,19] | IL10 | Il10-/- mice | Decrease in diversity and richness |
↑Proteobacteria and Escherichia coli (during onset of inflammation) | |||
↓Bacteroidetes and Firmicutes | |||
Current study | IL10RA | Human cohort | Decrease in diversity and increase in variability |
↑Firmicutes, Enterococcaceae, Enterococcus, Lactobacillales, Bacilli, and Micrococcales | |||
↓Bifidobacteriales, Bifidobacteriaceae, Bifidobacterium, Veillonellaceae, Clostridiales, Clostridia, Selenomonadales, and Negativicutes | |||
[4,7,20] | NOD2 | Human cohort | ↓Roseburia, Faecalibacterium prausnitzii, Bacteroides and Bacteroidia |
↑Eubacteriaceae and Enterobacteriaceae | |||
[21] | NOD2 | Nod2-/- mice | Decrease in diversity and richness |
↑Bacteroides, Bacteroidaceae, and B.acidifaciens | |||
↓Proteobacteria, Helicobacter hepaticus, and Desulfovibro spp | |||
[22] | ATG16L1 | Human cohort | ↑Fusobacteriaceae |
[4] | CARD9 | Human cohort | ↓Firmicutes |
[23] | CARD9 | Card9-/- mice | Decreased stability |
↓Adlercreutzia, Actinobacteria, and Lactobacillus reuteri |